Obsidian Therapeutics Inc. (OBX)
$16.00
vs last close−1.00 (−5.87%)
Something off on this page? Send us feedback.
Obsidian Therapeutics Inc.OBX
Health CareNot reported.
Company facts
CEOMadan Jagasia
ListedAug 4, 2026
ExchangeNASDAQ
HeadquartersCambridge, MA
CountryUnited States
Employees3
CIK0002130606
ISINUS67448A1060
Market cap$17.7M
EPS (ttm)—
P/E (ttm)—
ROE—
P/B—
P/S—
Dividend yieldDiv yield—
Beta—
No analyst consensus on record.
EPSReportedEstimate
———Aug '23Nov '23May '24Aug '24Aug '26
Reported———−$96.00−$66.00−$16.00−$14.00−$1.71
Estimate———−$75.66−$79.44−$58.89$165.45−$1.63
Surprise———−26.9%+16.9%+72.8%−108.5%−4.9%
RevenueReportedEstimate
———Aug '23Nov '23May '24Aug '24Aug '26
Reported————————
Estimate——————$50.0M—
Surprise————————
Estimate−$1.63
Reported−$1.71−4.9%
Estimate—
Reported—
Not reported.
No dividends on record.
1.04M company shares as of Aug 22, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Deep Track Capital, LPStrategic | —5.37% of class, as filed | — | filed Aug 11, 2026 |
Novo Holdings A/SStrategic | —5.10% of class, as filed | — | filed Aug 10, 2026 |
RA Capital Management, L.P.Institution | —9.70% of class, as filed | — | filed Aug 10, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
Not reported.